Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL31437052

O=C(O)C(F)(F)F.O=C1CCN(c2ccc(N3CCNCC3)cc2F)C(=O)N1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 5/20 0.39
CRBN Q96SW2 5/20 0.39
F10 P00742 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
PDK2 Q15119 1/20 0.38
ABHD6 Q9BV23 1/20 0.38
TSHR P16473 2/20 0.37
BRD4 O60885 1/20 0.37
HTT P42858 1/20 0.37
CYP2J2 P51589 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
DRD3 P35462 1/20 0.36
HTR6 P50406 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL31630905 0.91 DDB1 (0.39) DDB1CRBNALDH1A1HSD17B10KDM4E
SCHEMBL27039415 0.91 CRBN (0.46) DDB1CRBNHTTDRD3HTR6
Trifluoroacetic Acid SCHEMBL31583715 0.86 CRBN (0.37) DDB1CRBNF10MAOAMAOB
Trifluoroacetic Acid SCHEMBL31630892 0.85 DDB1 (0.52) DDB1CRBNMAOBALDH1A1HSD17B10
Trifluoroacetic Acid SCHEMBL31630912 0.83 PKM (0.43) DDB1CRBNLMNAABHD6DRD3
Trifluoroacetic Acid SCHEMBL30525331 0.83 DDB1 (0.55) DDB1CRBNALDH1A1PDK2HTT
Trifluoroacetic Acid SCHEMBL31583511 0.83 RAD52 (0.41) DDB1CRBNF10MAOAMAOB
SCHEMBL31437046 0.81 CRBN (0.49) DDB1CRBNF10ALDH1A1HSD17B10
SCHEMBL26641696 0.81 HTR3E (0.43) DDB1CRBNALDH1A1PDK2HTR3E
SCHEMBL27023026 0.80 NOTUM (0.44) DDB1CRBNPDK2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed